Specific reversal agents in acute stroke
Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti · 2024
DOI: 10.21857/9e31lhzpkm ↗Kurz gefasst
Fachartikel in der Zeitschrift Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti, 2024. Verfasst von Senta Frol.
Themen: Schlaganfall
Abstract (Originalsprache)
Direct oral anticoagulants (DOACs) are first line therapy in primary and secondary stroke prevention in patients with non-valvular atrial fibrillation.Regardless of their use a minority of patients still suffer acute stroke (ischemic or hemorrhagic).Specific reversal agents changed concept of therapy in DOACtreated patients with acute stroke.In this manuscript data on randomized controlled trials, real-world evidence and proposed standard operating procedures are summarized.
Zitieren
APA
Frol, S. (2024). Specific reversal agents in acute stroke. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti. https://doi.org/10.21857/9e31lhzpkm
Vancouver
Frol S. Specific reversal agents in acute stroke. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti. 2024. doi:10.21857/9e31lhzpkm
BibTeX
@article{Frol2024,
author = {Frol, Senta},
title = {Specific reversal agents in acute stroke},
journal = {Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti},
year = {2024},
doi = {10.21857/9e31lhzpkm}
}
EUVIMED